Operator
Welcome to the Q1 2021 Athenex, Inc. Earnings Conference Call. My name is Richard, and I ll be your operator for today s call. [Operator Instructions]
I am now going to call over Mr. Steven Rubis, Senior Director, Investor Relations. Steven, you may begin.
Steven Rubis
Investor Relations
Good morning, and thank you for joining our conference call. Today, we will provide an update on Athenex s business as well as a review of financial results for the first quarter of 2021. The news release detailing the results crossed the wire earlier this morning and is available on the company s website. A replay of this call will also be archived on the company website. During the conference call, the company will make projections or forward-looking statements regarding future events, including statements about financial, business and clinical milestones anticipated in fiscal year 2021 and beyond. We encourage you to review the company s past and future filings with the SEC, which
Operator
Greetings and welcome to the Athenex, Inc. Fourth Quarter and Fiscal Year 2020 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Steve Rubis, Senior Director of Investor Relations for Athenex. Thank you. You may begin.
Steven Rubis
Senior Director, Investor Relations
Good morning and thank you for joining our conference call. This morning, we published two press releases. The first announces that we received a complete response letter from the FDA for Oral Paclitaxel. The second announces our fourth quarter and full year 2020 financial results. These news releases crossed the wire earlier this morning and are available on our website. Today, we will provide an update on Athenex s business as well as a review of financial results for the fourth quarter and full year 2020. A replay of this call will also be archived on the company website.